Skip to main content
ADTX
NASDAQ Life Sciences

Aditxt Finalizes Prospectus for Resale of 148.2M Shares by Selling Stockholders, Warrants Out-of-the-Money

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
8
Price
$0.275
Mkt Cap
$261.753K
52W Low
$0.276
52W High
$2,495.018
Market data snapshot near publication time

Summary

Aditxt has filed a prospectus for the resale of up to 148.28 million shares by selling stockholders upon the exercise of various warrants at $0.50 per share, creating a significant overhang despite the warrants currently being out-of-the-money.


Key Events

  • Massive Share Overhang Enabled

    The filing enables selling stockholders to resell up to 148,278,241 shares of common stock upon the exercise of various outstanding warrants.

  • Warrants Currently Out-of-the-Money

    The warrants have an exercise price of $0.50 per share, which is significantly higher than the current market price of $0.27 per share, making cash exercise for immediate profit unlikely.

  • Uncertain Cash Proceeds for Company

    Aditxt will not receive any proceeds from the resale of shares by selling stockholders. While the company could receive up to $74.14 million if all warrants are exercised for cash, this is highly uncertain given the current stock price.

  • Context of Financial Distress

    This potential dilution occurs as the company faces substantial doubt about its ability to continue as a going concern and significant Nasdaq delisting risk, as previously disclosed in its annual report.


Analysis

This prospectus supplement finalizes the terms of the S-3 registration filed on April 11, 2026, enabling selling stockholders to resell up to 148.28 million shares upon the exercise of various warrants. While the company could receive up to $74.14 million if all warrants are exercised for cash, the exercise price of $0.50 per share is currently above the market price of $0.27, making cash exercise unlikely unless the stock price significantly recovers. This creates a substantial share overhang and potential dilution for a company already facing a going concern warning and Nasdaq delisting risk, as highlighted in its recent 10-K and an 8-K detailing restrictive debt.

At the time of this filing, ADTX was trading at $0.27 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $261.8K. The 52-week trading range was $0.28 to $2,495.02. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ADTX - Latest Insights

ADTX
Jun 16, 2026, 9:14 AM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $0.0132
Real-time Price: $0.0064 info
Change: -$0.0068 (-52%) info
Market Cap: $5.222K info
ADTX
Jun 11, 2026, 3:09 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $0.0124
Real-time Price: $0.0064 info
Change: -$0.0060 (-48%) info
Market Cap: $5.222K info
ADTX
Jun 10, 2026, 5:30 PM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $0.0189
Real-time Price: $0.0064 info
Change: -$0.0125 (-66%) info
Market Cap: $5.222K info
ADTX
Jun 10, 2026, 3:13 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $0.029
Real-time Price: $0.0064 info
Change: -$0.0226 (-78%) info
Market Cap: $5.222K info
ADTX
Jun 09, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.033
Real-time Price: $0.0064 info
Change: -$0.0266 (-81%) info
Market Cap: $5.222K info
ADTX
Jun 09, 2026, 7:45 AM EDT
Source: Dow Jones Newswires
Importance Score:
10
Price at Filing: $0.04803
Real-time Price: $0.0064 info
Change: -$0.04163 (-87%) info
Market Cap: $5.222K info
ADTX
Jun 05, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.0597
Real-time Price: $0.0064 info
Change: -$0.0533 (-89%) info
Market Cap: $5.222K info
ADTX
Jun 01, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.0999
Real-time Price: $0.0064 info
Change: -$0.0935 (-94%) info
Market Cap: $5.222K info
ADTX
May 29, 2026, 4:21 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.142
Real-time Price: $0.0064 info
Change: -$0.1356 (-95%) info
Market Cap: $5.222K info
ADTX
May 22, 2026, 5:03 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $0.480
Real-time Price: $0.0064 info
Change: -$0.4736 (-99%) info
Market Cap: $5.222K info